Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users

Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern pathology 2003-04, Vol.16 (4), p.286-292
Hauptverfasser: Ganesan, Santhi, Felo, Joseph, Saldana, Mario, Kalasinsky, Victor F, Lewin-Smith, Michael R, Tomashefski, Joseph F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 4
container_start_page 286
container_title Modern pathology
container_volume 16
creator Ganesan, Santhi
Felo, Joseph
Saldana, Mario
Kalasinsky, Victor F
Lewin-Smith, Michael R
Tomashefski, Joseph F
description Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tissue from three adult IV drug users, 1 man and 2 women, whose ages respectively were 27, 38, and 40 years. Suspected crospovidone was compared with pharmaceutical-grade crospovidone by means of histochemical stains, transmission electron microscopy, and infrared spectroscopy. Similar particles were also observed by light microscopy in a 4-mg tablet of hydromorphone, a preparation prescribed to two of the patients. Two patients had sickle cell disease and were taking methadone and/or hydromorphone for pain management; the third was receiving parenteral hyperalimentation after small bowel resection. Crospovidone appeared as deeply basophilic, coral-like particles within pulmonary arteries and in extravascular foreign-body granulomas. Intrapulmonary crospovidone stained similarly to the pure substance, including intense staining with mucicarmine, Congo red, and Masson trichrome. With Movat pentachrome stain, both intravascular and purified crospovidone appeared orange-yellow, whereas most interstitial particles associated with giant cells stained blue-green. Alcian blue failed to stain intravascular or purified crospovidone but strongly decorated some phagocytized particles. Ultrastructurally, both purified powder and tissue deposits of crospovidone appeared as irregular, electron dense, laminated, and finely granular material. Intrapulmonary crospovidone was associated with inflammatory cells and exhibited degenerative changes. By infrared spectroscopy, crospovidone in tissue had the same spectral characteristics as pharmaceutical grade crospovidone and the library reference, polyvinylpyrrolidone (PVP). We conclude that crospovidone contributes to pulmonary vascular injury in some persons who illicitly inject pharmaceutical tablets. It is readily identifiable histologically and distinguishable from other tablet constituents, such as cornstarch, talc, and microcrystalline cellulose. The variable staining with Alcian blue and Movat suggests that crospovidone is altered in vivo by the inflammatory response.
doi_str_mv 10.1097/01.MP.0000062653.65441.DA
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_221233549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0893395222050207</els_id><sourcerecordid>984481911</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-aa14f602ff7bfb47f91e7fe5a985a5422e3b10c96a1ca87f997a061af8fdf37a3</originalsourceid><addsrcrecordid>eNqNkM9v0zAcxS0EYmXwJ4AMJ3ZI5h9xYnOr2gGTurEDO03IcpKvS6bWDnZSqfz1uEtFr_PFh_d579kPoY-U5JSo6pLQ_OYuJ4dTslLwvBRFQfPl_AWaUcFJRpgUL9GMSMUzrgQ7Q29ifCSEFkKy1-iMslIxqtgMPVxta7_p_kKLF8HH3u-61jvAn3u_2T_cZrvO7TcZy_p9CIk7aL8ucOfw8BvwanTriL3F124IZgfOjxEvw7jG9xFCfIteWbOJ8O54n6P7r1c_F9-z1Y9v14v5KmuEJENmDC1sSZi1VW3rorKKQmVBGCWFEQVjwGtKGlUa2hiZZFUZUlJjpW0trww_R5-m3D74PyPEQT_6MbhUqRmjjHNRqASpCWrSN2MAq_vQbU3Ya0r0YVVNqL6506dV9dOqejlP3g_HgrHeQntyHmdMwJcJiElyawinFzwn_f1kdmYYA_xP51KSqiRJX0w6pA13XQqPTQeugbYL0Ay69d0zWv4B0k6kTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221233549</pqid></control><display><type>article</type><title>Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><source>ProQuest Central</source><creator>Ganesan, Santhi ; Felo, Joseph ; Saldana, Mario ; Kalasinsky, Victor F ; Lewin-Smith, Michael R ; Tomashefski, Joseph F</creator><creatorcontrib>Ganesan, Santhi ; Felo, Joseph ; Saldana, Mario ; Kalasinsky, Victor F ; Lewin-Smith, Michael R ; Tomashefski, Joseph F</creatorcontrib><description>Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tissue from three adult IV drug users, 1 man and 2 women, whose ages respectively were 27, 38, and 40 years. Suspected crospovidone was compared with pharmaceutical-grade crospovidone by means of histochemical stains, transmission electron microscopy, and infrared spectroscopy. Similar particles were also observed by light microscopy in a 4-mg tablet of hydromorphone, a preparation prescribed to two of the patients. Two patients had sickle cell disease and were taking methadone and/or hydromorphone for pain management; the third was receiving parenteral hyperalimentation after small bowel resection. Crospovidone appeared as deeply basophilic, coral-like particles within pulmonary arteries and in extravascular foreign-body granulomas. Intrapulmonary crospovidone stained similarly to the pure substance, including intense staining with mucicarmine, Congo red, and Masson trichrome. With Movat pentachrome stain, both intravascular and purified crospovidone appeared orange-yellow, whereas most interstitial particles associated with giant cells stained blue-green. Alcian blue failed to stain intravascular or purified crospovidone but strongly decorated some phagocytized particles. Ultrastructurally, both purified powder and tissue deposits of crospovidone appeared as irregular, electron dense, laminated, and finely granular material. Intrapulmonary crospovidone was associated with inflammatory cells and exhibited degenerative changes. By infrared spectroscopy, crospovidone in tissue had the same spectral characteristics as pharmaceutical grade crospovidone and the library reference, polyvinylpyrrolidone (PVP). We conclude that crospovidone contributes to pulmonary vascular injury in some persons who illicitly inject pharmaceutical tablets. It is readily identifiable histologically and distinguishable from other tablet constituents, such as cornstarch, talc, and microcrystalline cellulose. The variable staining with Alcian blue and Movat suggests that crospovidone is altered in vivo by the inflammatory response.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1097/01.MP.0000062653.65441.DA</identifier><identifier>PMID: 12692192</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Adult ; Blood Vessels - pathology ; Blood Vessels - ultrastructure ; Crospovidone ; Female ; Foreign body emboli ; Foreign-Body Reaction - etiology ; Humans ; Hydromorphone - administration &amp; dosage ; Hydromorphone - adverse effects ; Intravenous drug use ; Laboratory Medicine ; Lung Diseases - etiology ; Lung Diseases - pathology ; Male ; Medicine ; Medicine &amp; Public Health ; Microscopy, Electron ; N-vinyl-2-pyrrolidone ; Narcotics - administration &amp; dosage ; Narcotics - adverse effects ; original-article ; Pathology ; Pharmaceutic Aids - adverse effects ; Polyvinylpyrrolidone ; Povidone - adverse effects ; Pulmonary Embolism - pathology ; Spectrophotometry, Infrared ; Substance Abuse, Intravenous - complications ; Substance Abuse, Intravenous - pathology ; Tablets</subject><ispartof>Modern pathology, 2003-04, Vol.16 (4), p.286-292</ispartof><rights>2003 United States &amp; Canadian Academy of Pathology</rights><rights>The United States and Canadian Academy of Pathology, Inc. 2003</rights><rights>Copyright Nature Publishing Group Apr 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-aa14f602ff7bfb47f91e7fe5a985a5422e3b10c96a1ca87f997a061af8fdf37a3</citedby><cites>FETCH-LOGICAL-c580t-aa14f602ff7bfb47f91e7fe5a985a5422e3b10c96a1ca87f997a061af8fdf37a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/221233549?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12692192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ganesan, Santhi</creatorcontrib><creatorcontrib>Felo, Joseph</creatorcontrib><creatorcontrib>Saldana, Mario</creatorcontrib><creatorcontrib>Kalasinsky, Victor F</creatorcontrib><creatorcontrib>Lewin-Smith, Michael R</creatorcontrib><creatorcontrib>Tomashefski, Joseph F</creatorcontrib><title>Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tissue from three adult IV drug users, 1 man and 2 women, whose ages respectively were 27, 38, and 40 years. Suspected crospovidone was compared with pharmaceutical-grade crospovidone by means of histochemical stains, transmission electron microscopy, and infrared spectroscopy. Similar particles were also observed by light microscopy in a 4-mg tablet of hydromorphone, a preparation prescribed to two of the patients. Two patients had sickle cell disease and were taking methadone and/or hydromorphone for pain management; the third was receiving parenteral hyperalimentation after small bowel resection. Crospovidone appeared as deeply basophilic, coral-like particles within pulmonary arteries and in extravascular foreign-body granulomas. Intrapulmonary crospovidone stained similarly to the pure substance, including intense staining with mucicarmine, Congo red, and Masson trichrome. With Movat pentachrome stain, both intravascular and purified crospovidone appeared orange-yellow, whereas most interstitial particles associated with giant cells stained blue-green. Alcian blue failed to stain intravascular or purified crospovidone but strongly decorated some phagocytized particles. Ultrastructurally, both purified powder and tissue deposits of crospovidone appeared as irregular, electron dense, laminated, and finely granular material. Intrapulmonary crospovidone was associated with inflammatory cells and exhibited degenerative changes. By infrared spectroscopy, crospovidone in tissue had the same spectral characteristics as pharmaceutical grade crospovidone and the library reference, polyvinylpyrrolidone (PVP). We conclude that crospovidone contributes to pulmonary vascular injury in some persons who illicitly inject pharmaceutical tablets. It is readily identifiable histologically and distinguishable from other tablet constituents, such as cornstarch, talc, and microcrystalline cellulose. The variable staining with Alcian blue and Movat suggests that crospovidone is altered in vivo by the inflammatory response.</description><subject>Adult</subject><subject>Blood Vessels - pathology</subject><subject>Blood Vessels - ultrastructure</subject><subject>Crospovidone</subject><subject>Female</subject><subject>Foreign body emboli</subject><subject>Foreign-Body Reaction - etiology</subject><subject>Humans</subject><subject>Hydromorphone - administration &amp; dosage</subject><subject>Hydromorphone - adverse effects</subject><subject>Intravenous drug use</subject><subject>Laboratory Medicine</subject><subject>Lung Diseases - etiology</subject><subject>Lung Diseases - pathology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microscopy, Electron</subject><subject>N-vinyl-2-pyrrolidone</subject><subject>Narcotics - administration &amp; dosage</subject><subject>Narcotics - adverse effects</subject><subject>original-article</subject><subject>Pathology</subject><subject>Pharmaceutic Aids - adverse effects</subject><subject>Polyvinylpyrrolidone</subject><subject>Povidone - adverse effects</subject><subject>Pulmonary Embolism - pathology</subject><subject>Spectrophotometry, Infrared</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Substance Abuse, Intravenous - pathology</subject><subject>Tablets</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkM9v0zAcxS0EYmXwJ4AMJ3ZI5h9xYnOr2gGTurEDO03IcpKvS6bWDnZSqfz1uEtFr_PFh_d579kPoY-U5JSo6pLQ_OYuJ4dTslLwvBRFQfPl_AWaUcFJRpgUL9GMSMUzrgQ7Q29ifCSEFkKy1-iMslIxqtgMPVxta7_p_kKLF8HH3u-61jvAn3u_2T_cZrvO7TcZy_p9CIk7aL8ucOfw8BvwanTriL3F124IZgfOjxEvw7jG9xFCfIteWbOJ8O54n6P7r1c_F9-z1Y9v14v5KmuEJENmDC1sSZi1VW3rorKKQmVBGCWFEQVjwGtKGlUa2hiZZFUZUlJjpW0trww_R5-m3D74PyPEQT_6MbhUqRmjjHNRqASpCWrSN2MAq_vQbU3Ya0r0YVVNqL6506dV9dOqejlP3g_HgrHeQntyHmdMwJcJiElyawinFzwn_f1kdmYYA_xP51KSqiRJX0w6pA13XQqPTQeugbYL0Ay69d0zWv4B0k6kTg</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>Ganesan, Santhi</creator><creator>Felo, Joseph</creator><creator>Saldana, Mario</creator><creator>Kalasinsky, Victor F</creator><creator>Lewin-Smith, Michael R</creator><creator>Tomashefski, Joseph F</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20030401</creationdate><title>Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users</title><author>Ganesan, Santhi ; Felo, Joseph ; Saldana, Mario ; Kalasinsky, Victor F ; Lewin-Smith, Michael R ; Tomashefski, Joseph F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-aa14f602ff7bfb47f91e7fe5a985a5422e3b10c96a1ca87f997a061af8fdf37a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Blood Vessels - pathology</topic><topic>Blood Vessels - ultrastructure</topic><topic>Crospovidone</topic><topic>Female</topic><topic>Foreign body emboli</topic><topic>Foreign-Body Reaction - etiology</topic><topic>Humans</topic><topic>Hydromorphone - administration &amp; dosage</topic><topic>Hydromorphone - adverse effects</topic><topic>Intravenous drug use</topic><topic>Laboratory Medicine</topic><topic>Lung Diseases - etiology</topic><topic>Lung Diseases - pathology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microscopy, Electron</topic><topic>N-vinyl-2-pyrrolidone</topic><topic>Narcotics - administration &amp; dosage</topic><topic>Narcotics - adverse effects</topic><topic>original-article</topic><topic>Pathology</topic><topic>Pharmaceutic Aids - adverse effects</topic><topic>Polyvinylpyrrolidone</topic><topic>Povidone - adverse effects</topic><topic>Pulmonary Embolism - pathology</topic><topic>Spectrophotometry, Infrared</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Substance Abuse, Intravenous - pathology</topic><topic>Tablets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ganesan, Santhi</creatorcontrib><creatorcontrib>Felo, Joseph</creatorcontrib><creatorcontrib>Saldana, Mario</creatorcontrib><creatorcontrib>Kalasinsky, Victor F</creatorcontrib><creatorcontrib>Lewin-Smith, Michael R</creatorcontrib><creatorcontrib>Tomashefski, Joseph F</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ganesan, Santhi</au><au>Felo, Joseph</au><au>Saldana, Mario</au><au>Kalasinsky, Victor F</au><au>Lewin-Smith, Michael R</au><au>Tomashefski, Joseph F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>16</volume><issue>4</issue><spage>286</spage><epage>292</epage><pages>286-292</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets. It can potentially embolize to the lung when aqueous tablet suspensions are injected intravenously. In this report, we identified embolized crospovidone in autopsy-derived lung tissue from three adult IV drug users, 1 man and 2 women, whose ages respectively were 27, 38, and 40 years. Suspected crospovidone was compared with pharmaceutical-grade crospovidone by means of histochemical stains, transmission electron microscopy, and infrared spectroscopy. Similar particles were also observed by light microscopy in a 4-mg tablet of hydromorphone, a preparation prescribed to two of the patients. Two patients had sickle cell disease and were taking methadone and/or hydromorphone for pain management; the third was receiving parenteral hyperalimentation after small bowel resection. Crospovidone appeared as deeply basophilic, coral-like particles within pulmonary arteries and in extravascular foreign-body granulomas. Intrapulmonary crospovidone stained similarly to the pure substance, including intense staining with mucicarmine, Congo red, and Masson trichrome. With Movat pentachrome stain, both intravascular and purified crospovidone appeared orange-yellow, whereas most interstitial particles associated with giant cells stained blue-green. Alcian blue failed to stain intravascular or purified crospovidone but strongly decorated some phagocytized particles. Ultrastructurally, both purified powder and tissue deposits of crospovidone appeared as irregular, electron dense, laminated, and finely granular material. Intrapulmonary crospovidone was associated with inflammatory cells and exhibited degenerative changes. By infrared spectroscopy, crospovidone in tissue had the same spectral characteristics as pharmaceutical grade crospovidone and the library reference, polyvinylpyrrolidone (PVP). We conclude that crospovidone contributes to pulmonary vascular injury in some persons who illicitly inject pharmaceutical tablets. It is readily identifiable histologically and distinguishable from other tablet constituents, such as cornstarch, talc, and microcrystalline cellulose. The variable staining with Alcian blue and Movat suggests that crospovidone is altered in vivo by the inflammatory response.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>12692192</pmid><doi>10.1097/01.MP.0000062653.65441.DA</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2003-04, Vol.16 (4), p.286-292
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_journals_221233549
source MEDLINE; Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection; ProQuest Central
subjects Adult
Blood Vessels - pathology
Blood Vessels - ultrastructure
Crospovidone
Female
Foreign body emboli
Foreign-Body Reaction - etiology
Humans
Hydromorphone - administration & dosage
Hydromorphone - adverse effects
Intravenous drug use
Laboratory Medicine
Lung Diseases - etiology
Lung Diseases - pathology
Male
Medicine
Medicine & Public Health
Microscopy, Electron
N-vinyl-2-pyrrolidone
Narcotics - administration & dosage
Narcotics - adverse effects
original-article
Pathology
Pharmaceutic Aids - adverse effects
Polyvinylpyrrolidone
Povidone - adverse effects
Pulmonary Embolism - pathology
Spectrophotometry, Infrared
Substance Abuse, Intravenous - complications
Substance Abuse, Intravenous - pathology
Tablets
title Embolized Crospovidone (poly[N-vinyl-2-pyrrolidone]) in the Lungs of Intravenous Drug Users
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T15%3A14%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Embolized%20Crospovidone%20(poly%5BN-vinyl-2-pyrrolidone%5D)%20in%20the%20Lungs%20of%20Intravenous%20Drug%20Users&rft.jtitle=Modern%20pathology&rft.au=Ganesan,%20Santhi&rft.date=2003-04-01&rft.volume=16&rft.issue=4&rft.spage=286&rft.epage=292&rft.pages=286-292&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1097/01.MP.0000062653.65441.DA&rft_dat=%3Cproquest_cross%3E984481911%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221233549&rft_id=info:pmid/12692192&rft_els_id=S0893395222050207&rfr_iscdi=true